THE PRESENT INVENTION RELATES TO NOVEL ANTAGONISTS FOR CCR2 (CC CHEMOKINE RECEPTOR 2) OF FORMULA (I) AND THEIR USE FOR PROVIDING MEDICAMENTS FOR TREATING CONDITIONS AND DISEASES, ESPECIALLY PULMONARY DISEASES LIKE ASTHMA AND COPD. (NO SUITABLE FIGURE)